Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

JB Chemicals & Pharmaceuticals Q4 FY26 Results: Net Profit ₹101.4 Cr, Down 30.4% YoY

JB Chemicals & Pharmaceuticals Ltd reported revenue from operations of ₹904.2 Cr (-4.8% YoY) and net profit of ₹101.4 Cr (-30.4% YoY) for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations904.21064.7949.5
Other income12.018.314.5
Total income916.21083.0964.0
Profit before exceptional items & tax161.9266.9193.0
Exceptional items-27.20.00.0
Profit before tax134.7266.9193.0
Net profit101.4197.9145.7
Operating margin14.7%24.6%20.0%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year-30.40%
Net profit, quarter on quarter-48.80%
Revenue, year on year-4.80%
Source

BSE results filing, NSE: JBCHEPHARM. Figures extracted from the filing.

Read the filing ↗

More from JB Chemicals & Pharmaceuticals Ltd

All →
18:49 IST NSE
Merger & Restructuring

Jb Chemicals & Pharmaceuticals Merger & Restructuring

JB Chemicals & Pharmaceuticals' amalgamation with Torrent Pharmaceuticals received NCLT sanction. The scheme will become effective upon filing with the Registrar of Companies.

18:03 IST BSE
Management Change

Jb Chemicals & Pharmaceuticals Management Change

Pradeep Kumar Singh and Suresh Bhise retired from the company. These changes in senior management are effective from June 30, 2026.

10:59 IST NSE
Price Movement Clarification

Jb Chemicals & Pharmaceuticals Price Movement Clarification

JB Chemicals clarified its audited financial results to the exchange. The board-approved results were signed by a director as authorized.

18:08 IST BSE
Management Change

Jb Chemicals & Pharmaceuticals Management Change

Mr. Bhushan Sachdev resigned as Executive Vice President – Supply Chain Management effective June 12, 2026. Investors should note the departure of a key supply chain executive.

18:37 IST NSE
Annual Report

Jb Chemicals & Pharmaceuticals Annual Report

JB Chemicals & Pharmaceuticals Limited filed its Business Responsibility and Sustainability Report for FY 2025-26. The report details company ESG performance, sustainability targets, and governance frameworks.

17:22 IST BSE
Annual Report

Jb Chemicals & Pharmaceuticals Annual Report

JB Chemicals & Pharmaceuticals filed its FY26 Business Responsibility and Sustainability Report. The filing highlights its ₹3889.89 Crore turnover and ESG progress for investor review.

Value
₹3,890 Cr